|
 |
|
|||||||
|
|||||||||
DOI: 10.2337/dc06-9916
© 2006 by the American Diabetes Association
Reviews/Commentaries/ADA Statements |
Hyperglycemic Crises in Adult Patients With Diabetes
A consensus statement from the American Diabetes Association
1 Division of Endocrinology, Diabetes, and Metabolism, University of Tennessee Health Science Center, Memphis, Tennessee
2 Clinical Research Center and Diabetes Unit, Grady Memorial Hospital/Emory University School of Medicine
3 Teaching Faculty, University of South Alabama, Baptist Health System, Birmingham, Alabama
Address correspondence and reprint requests to Dr. Abbas E. Kitabchi, Director, Division of Endocrinology, Diabetes and Metabolism, University of Tennessee Health Science Center, 956 Court Ave., Suite D334, Memphis, Tennessee 38163. E-mail: akitabchi@utmem.edu
Abbreviations: ß-OHB, ß-hydroxybutyrate • DKA, diabetic ketoacidosis • HHS, hyperosmolar hyperglycemic state
| The first 300 words of the full text of this article appear below. |
 |
INTRODUCTION |
|---|
Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) are the two most serious acute metabolic complications of diabetes. Most patients with DKA have autoimmune type 1 diabetes; however, patients with type 2 diabetes are also at risk during the catabolic stress of acute illness such as trauma, surgery, or infection. Table 1 outlines the diagnostic criteria and electrolyte and fluid deficits for both disorders. The mortality rate in patients with DKA is <5% in experienced centers, whereas the mortality rate of patients with HHS still remains high at
11% (1–8). Death in these conditions is rarely due to the metabolic complications of hyperglycemia or ketoacidosis but rather relates to the underlying precipitating illness. The prognosis of both conditions is substantially worsened at the extremes of age and in the presence of coma and hypotension (7,9–11)
|
This consensus statement will outline precipitating factors and recommendations for the diagnosis, treatment, and prevention of DKA and HHS in adult subjects. It is based on a previous technical review and more recently published peer-reviewed articles since 2001, which should be consulted for further information.
|
PATHOGENESIS— |
|---|
Although the pathogenesis of DKA is better understood than that of HHS, the basic underlying mechanism for both disorders is a reduction in the net effective action of circulating insulin coupled with a concomitant elevation of counterregulatory hormones, such as glucagon, catecholamines, cortisol, and growth hormone (1,3,4,8–13). DKA and HHS can fall anywhere along the disease continuum of diabetic metabolic derangements. At one extreme, pure DKA without significant hyperosmolarity typically indicates the total or relative absence of insulin (seen in type 1 diabetes). At the
|
PRECIPITATING FACTORS— |
|---|
|
DIAGNOSIS |
|---|
History and physical examination
Laboratory findings
Differential diagnosis
|
TREATMENT— |
|---|
Fluid therapy
Insulin therapy
Potassium
Bicarbonate
Phosphate
|
COMPLICATIONS— |
|---|
|
PREVENTION— |
|---|
|
NOTE ADDED IN PROOF— |
|---|
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  A. E. Kitabchi, M. B. Murphy, J. Spencer, R. Matteri, and J. Karas Is a Priming Dose of Insulin Necessary in a Low-Dose Insulin Protocol for the Treatment of Diabetic Ketoacidosis? Diabetes Care, November 1, 2008; 31(11): 2081 - 2085. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Balasubramanyam, R. Nalini, C. S. Hampe, and M. Maldonado Syndromes of Ketosis-Prone Diabetes Mellitus Endocr. Rev., May 1, 2008; 29(3): 292 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Kitzmiller, J. M. Block, F. M. Brown, P. M. Catalano, D. L. Conway, D. R. Coustan, E. P. Gunderson, W. H. Herman, L. D. Hoffman, M. Inturrisi, et al. Managing Preexisting Diabetes for Pregnancy: Summary of evidence and consensus recommendations for care Diabetes Care, May 1, 2008; 31(5): 1060 - 1079. [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Kitabchi, G. E. Umpierrez, J. N. Fisher, M. B. Murphy, and F. B. Stentz Thirty Years of Personal Experience in Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1541 - 1552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sheikh-Ali, B. S. Karon, A. Basu, Y. C. Kudva, L. A. Muller, J. Xu, W. F. Schwenk, and J. M. Miles Can Serum {beta}-Hydroxybutyrate Be Used to Diagnose Diabetic Ketoacidosis? Diabetes Care, April 1, 2008; 31(4): 643 - 647. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. E. Umpierrez, D. Smiley, A. Zisman, L. M. Prieto, A. Palacio, M. Ceron, A. Puig, and R. Mejia Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes (RABBIT 2 Trial) Diabetes Care, September 1, 2007; 30(9): 2181 - 2186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Rosival Hyperglycemic Crises in Adult Patients With Diabetes: A Consensus Statement From the American Diabetes Association: Response to Kitabchi et al. Diabetes Care, July 1, 2007; 30(7): e75 - e75. [Full Text] [PDF]
|
|
|
|
|
|
A. E. Kitabchi, G. E. Umpierrez, M. B. Murphy, and R. A. Kreisberg Hyperglycemic Crises in Adult Patients With Diabetes: A Consensus Statement From the American Diabetes Association: Response to Rosival Diabetes Care, July 1, 2007; 30(7): e76 - e76. [Full Text] [PDF]
|
|
|
|
 |
|
 K. K Dhatariya Diabetic ketoacidosis BMJ, June 23, 2007; 334(7607): 1284 - 1285. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |